Carotid artery revascularization using the Walrus balloon guide catheter: safety and feasibility from a US multicenter experience.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 16 08 2021
accepted: 03 10 2021
pubmed: 24 10 2021
medline: 22 6 2022
entrez: 23 10 2021
Statut: ppublish

Résumé

The Walrus balloon guide catheter (BGC) is a new generation of BGC, designed to eliminate conventional limitations during mechanical thrombectomy. To report a multi-institutional experience using this BGC for proximal flow control (PFC) in the setting of carotid artery angioplasty/stenting (CAS) in elective (eCAS) and tandem strokes (tCAS). Prospectively maintained databases at 8 North American centers were queried to identify patients with cervical carotid disease undergoing eCAS/tCAS with a Walrus BGC. 110 patients (median age 68, 64.6% male), 80 (72.7%) undergoing eCAS and 30 (27.3%) tCAS procedures, were included (median cervical carotid stenosis 90%; 46 (41.8%) with contralateral stenosis). Using a proximal flow-arrest technique in 95 (87.2%) and flow-reversal in 14 (12.8%) procedures, the Walrus was navigated into the common carotid artery successfully in all cases despite challenging arch anatomy (31, 28.2%), with preferred femoral access (103, 93.6%) and in monitored anesthesia care (90, 81.8%). Angioplasty and distal embolic protection devices (EPDs) were used in 91 (83.7%) and 58 (52.7%) procedures, respectively. tCAS led to a modified Thrombolysis in Cerebral Infarction 2b/3 in all cases. Periprocedural ischemic stroke (up to 30 days postoperatively) rate was 0.9% (n=1) and remote complications occurred in 2 (1.8%) cases. Last follow-up modified Rankin Scale score of 0-2 was seen in 95.3% of eCAS cohort, with no differences in complications in the eCAS subgroup between PFC only versus PFC and distal EPD (median follow-up 4.1 months). Walrus BGC for proximal flow control is safe and effective during eCAS and tCAS. Procedural success was achieved in all cases, with favorable safety and functional outcomes on short-term follow-up.

Identifiants

pubmed: 34686574
pii: neurintsurg-2021-018126
doi: 10.1136/neurintsurg-2021-018126
doi:

Types de publication

Journal Article Multicenter Study Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

709-717

Commentaires et corrections

Type : CommentIn
Type : CommentOn

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: PK is a member of the JNIS editorial board (education chair).

Auteurs

Mohamed M Salem (MM)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Svetlana Kvint (S)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Ammad A Baig (AA)

Department of Neurosurgery, University at Buffalo Jacobs School of Medicine and Biomedical Science, Buffalo, New York, USA.
Department of Neurosurgery, Gates Vascular Institute, Buffalo, New York, USA.

Andre Monteiro (A)

Department of Neurosurgery, University at Buffalo Jacobs School of Medicine and Biomedical Science, Buffalo, New York, USA.
Department of Neurosurgery, Gates Vascular Institute, Buffalo, New York, USA.

Gustavo M Cortez (GM)

Department of Cerebrovascular and Endovascular Surgery, Baptist Neurological Institute and Lyerly Neurosurgery, Jacksonville, Florida, USA.

Anna L Kuhn (AL)

Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Oded Goren (O)

Department of Neurosurgery, Geisinger Medical Center, Danville, Pennsylvania, USA.

Shamsher Dalal (S)

Department of Neurosurgery, Geisinger Medical Center, Danville, Pennsylvania, USA.

Brian T Jankowitz (BT)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Omar Choudhri (O)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Daniel Raper (D)

Department of Neurological Surgery, Baylor College of Medicine, Houston, Texas, USA.

Omar Tanweer (O)

Department of Neurological Surgery, Baylor College of Medicine, Houston, Texas, USA.

Pascal Jabbour (P)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Peter Kan (P)

Department of Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Robert M Starke (RM)

Department of Neurosurgery and Radiology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Elad I Levy (EI)

Department of Neurosurgery, University at Buffalo Jacobs School of Medicine and Biomedical Science, Buffalo, New York, USA.
Department of Neurosurgery, Gates Vascular Institute, Buffalo, New York, USA.

Christoph J Griessenauer (CJ)

Department of Neurosurgery, Geisinger Medical Center, Danville, Pennsylvania, USA.
Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.

Ajit S Puri (AS)

Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Ricardo Hanel (R)

Department of Cerebrovascular and Endovascular Surgery, Baptist Neurological Institute and Lyerly Neurosurgery, Jacksonville, Florida, USA.

Adnan H Siddiqui (AH)

Department of Neurosurgery, University at Buffalo Jacobs School of Medicine and Biomedical Science, Buffalo, New York, USA.
Department of Neurosurgery, Gates Vascular Institute, Buffalo, New York, USA.

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA Jan.Burkhardt@Pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH